Beyond precision therapy: the need for precision clinical decision-making in recurrent pericarditis

Q: What does this research mean for the field?

Management of recurrent pericarditis requires precision clinical decision-making beyond targeted pharmacotherapy alone. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

Tina Bečić; Mislav Radić; Josipa Radić

doi:10.55563/clinexprheumatol/0ofa2i

August 5, 2026Clinical and Experimental Rheumatology

Beyond precision therapy: the need for precision clinical decision-making in recurrent pericarditis

View at Publisher

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

Letters to the Editor; Authors: T. Bečić, M. Radić, J. Radić

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Bečić et al. (2026) studied this question.

synapsesocial.com/papers/6af354f15b67d29976ea0821 https://doi.org/10.55563/clinexprheumatol/0ofa2i

View at Publisher

Ask AI

Bookmark

Share

Beyond precision therapy: the need for precision clinical decision-making in recurrent pericarditis

No abstract yet

Ask about this paper

Abstract

Discussion

Cite This Study

Beyond precision therapy: the need for precision clinical decision-making in recurrent pericarditis

No abstract yet

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading